© 1992 Oxford University Press
research-article |
Subchronic (13-Week) Toxicity Studies of Oral Phenolphthalein in Fischer 344 Rats and B6C3F1 Mice
*Division of Toxicology Research and Testing, National Institute of Environmental Health Sciences, National Toxicology Program Research Triangle Park, North Carolina 27709
Microbiological Associates 5221 River Road, Bethesda, Maryland 20816
Received August 2, 1990; accepted July 18, 1991
Phenolphthalein is a cathartic agent that is widely used in over-the-counter laxatives. Thirteen-week toxicity studies of phenolphthalein were performed using F344/N rats and B6C3F1 mice. Rats and mice were fed ad libitum with a NIH 07 diet containing 0; 3000; 6000; 12,000; 25,000; or 50,000 ppm phenolphthalein. On a milligram per kilogram body weight basis, rats and mice fed 50,000 ppm phenolphthalein ingested more drug than would be expected during human laxative abuse. Phenolphthalein produced little evidence of toxicity in rats. There was slightly lower weight gain among the 25,000 and 50,000 ppm groups. Treated rats showed elevated relative kidney weights (males only) and elevated absolute and relative liver weights at 12,000–50,000 ppm phenolphthalein. Rat serum bile acids were depressed early (Days 5 and 6) by phenolphthalein treatment. Several treatment-related toxic effects, however, were identified in mice who received more phenolphthalein per unit body weight than rats. Although there were no effects on body weight gain, elevated liver weights were noted in female mice receiving 6000–50,000 ppm phenolphthalein. The primary treatment-related findings that occurred during the mouse studies involved the reproductive and hematopoietic systems. Reproductive changes including depressed testis and right epididymal weights and sperm density, an elevated production of abnormal sperm, and morphologic alterations in seminiferous tubules occurred at all levels of exposure (3000–50,000 ppm). Hematopoietic changes included bone marrow hypoplasia (12,000–50,000 ppm), increased splenic hematopoiesis (males only, 25,000 and 50,000 ppm), and an elevated incidence of micronucleated erythrocytes (6000–50,000 ppm).